Dr. Laura Collins, MB BS

• Cytopathology

• Anatomic & Clinical Pathology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Beth Israel Deaconess Medical Center

  Fellowship Hospital, 1998

• Westminster Medical School

  Medical School, 1990

• Estrogen Receptor-ß Expression in Invasive Breast Cancer in Relation to Molecular Phenotype: Results from the Nurses' Health Study, 2009-11-06

• Healthful and unhealthful plant-based diets and risk of breast cancer in U.S. women: results from the Nurses' Health Studies, 2021-07-21

• EXPRESSION OF IGF1R IN NORMAL BREAST TISSUE AND SUBSEQUENT RISK OF BREAST CANCER, 2011-01-01

• Sexual orientation and benign breast disease in a cohort of U.S. women, 2020-01-01

• The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study, 2011-03-09

• Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study, 2020-07-22

• Retinoblastoma protein expression and its predictors in triple-negative breast cancer, 2020-06-05

• Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer, 2020-03-13

• Comparison of molecular phenotypes of ductal carcinomain situand invasive breast cancer, 2008-08-05

• Variability in grading of ductal carcinomain situamong an international group of pathologists M van Seijenet al, 2021-02-23

• Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers, 2023-03-07

• Genetic Variation and Circulating Levels of IGF-I and IGFBP-3 in Relation to Risk of Proliferative Benign Breast Disease, 2010-01-01

• A Prospective study of Endometriosis and Risk of Benign Breast Disease, 2016-09-07

• Accuracy of screening mammography in women with a history of lobular carcinoma in-situ or atypical hyperplasia of the breast, 2014-05-07

• PAM50 Molecular Intrinsic Subtypes in the Nurses' Health Study Cohorts, 2018-12-27

• Traditional Breast Cancer Risk Factors in Relation to Molecular Subtypes of Breast Cancer, 2011-08-10

• Columnar cell lesions and subsequent breast cancer risk: a nested case-control study, 2010-08-06

• Lobule Type and Subsequent Breast Cancer Risk: Results from the Nurses' Health Studies, 2009-04-01

• Intakes of fat and micronutrients between ages 13 to 18 years and the incidence of proliferative benign breast disease, 2014-11-07

• Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer, 2016-10-26

• Adolescent Intakes of Vitamin D and Calcium and Incidence of Proliferative Benign Breast Disease, 2012-05-24

• Reproductive risk factors in relation to molecular subtypes of breast cancer: results from the Nurses' Health Studies, 2016-02-08

• Height and Body Size in Childhood, Adolescence and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies, 2016-07-23

• Prevalence and predictors of loss of wild typeBRCA1in estrogen receptor positive and negativeBRCA1-associated breast cancers, 2010-11-16

• Prevalence and predictors of androgen receptor and programmed death-ligand 1 inBRCA1-associated and sporadic triple-negative breast cancer, 2016-02-24

• Plasma 25-hydroxyvitamin D and risk of breast cancer in women followed over 20 years, 2016-08-16

• Radial scars and subsequent breast cancer risk: Results from the Nurses' Health Studies, 2013-04-23

• Reliability of a computational platform as a surrogate for manually interpreted immunohistochemical markers in breast tumor tissue microarrays, 2021-08-02

• Intake of Fiber and Nuts during Adolescence and Incidence of Proliferative Benign Breast Disease, 2010-03-14

• Androgen Receptor Expression in Breast Cancer in Relation to Molecular Phenotype: Results from the Nurses' Health Study, 2011-05-06

• The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease, 2021-03-05

• Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women, 2011-02-15

• Lifetime Physical Activity and the Incidence of Proliferative Benign Breast Disease, 2011-07-12

• Alcohol Consumption and Risk of Breast Cancer by Tumor Receptor Expression, 2015-09-18

• Molecular analysis of TCGA breast cancer histologic types, 2021-12-08

• Breast Cancer Risk by Extent and Type of Atypical Hyperplasia: An Update from the Nurses' Health Studies, 2015-11-13

• Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting, 2009-11-18

• Estrogen receptor positive breast cancers inBRCA1mutation carriers: clinical risk factors and pathologic features, 2010-02-11

• Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II, 2012-03-13

• Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype, 2013-08-23

• Relationship Between Clinical and Pathologic Features of Ductal Carcinoma in Situ and Patient Age: An Analysis of 657 Patients, 2009-08-29

• Continuous measurement of breast tumor hormone receptor expression: a comparison of two computational pathology platforms, 2016-10-11

• Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression, 2008-09-01

• Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses' Health Study, 2017-08-08

• Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies, 2019-03-12

• Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status, 2015-04-08